» Articles » PMID: 27065196

Structures of Human ADAR2 Bound to DsRNA Reveal Base-flipping Mechanism and Basis for Site Selectivity

Overview
Date 2016 Apr 12
PMID 27065196
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Adenosine deaminases acting on RNA (ADARs) are editing enzymes that convert adenosine to inosine in duplex RNA, a modification reaction with wide-ranging consequences in RNA function. Understanding of the ADAR reaction mechanism, the origin of editing-site selectivity, and the effect of mutations is limited by the lack of high-resolution structural data for complexes of ADARs bound to substrate RNAs. Here we describe four crystal structures of the human ADAR2 deaminase domain bound to RNA duplexes bearing a mimic of the deamination reaction intermediate. These structures, together with structure-guided mutagenesis and RNA-modification experiments, explain the basis of the ADAR deaminase domain's dsRNA specificity, its base-flipping mechanism, and its nearest-neighbor preferences. In addition, we identified an ADAR2-specific RNA-binding loop near the enzyme active site, thus rationalizing differences in selectivity observed between different ADARs. Finally, our results provide a structural framework for understanding the effects of ADAR mutations associated with human disease.

Citing Articles

Conformational reorganization and phase separation drive hyper-editing of ADR-2-ADBP-1 complex.

Mu J, Wu C, Xu K, Liu X, Fu Y, Zhang Z Nucleic Acids Res. 2025; 53(5).

PMID: 40037706 PMC: 11879458. DOI: 10.1093/nar/gkaf148.


Fine-tuning of the PPR protein directs the RNA editing activity toward C-to-U or U-to-C conversion.

Ichinose M, Teramoto T, Nakamura I, Shimajiri Y, Yagi Y, Gutmann B Sci Rep. 2025; 15(1):6288.

PMID: 39984571 PMC: 11845758. DOI: 10.1038/s41598-025-90722-9.


Enhancing RNA editing efficiency and specificity with engineered ADAR2 guide RNAs.

Ai X, Ding S, Zhou S, Du F, Liu S, Cui X Mol Ther Nucleic Acids. 2025; 36(1):102447.

PMID: 39967855 PMC: 11834095. DOI: 10.1016/j.omtn.2025.102447.


Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration.

Fry L, Major L, Salman A, McDermott L, Yang J, King A Commun Biol. 2025; 8(1):200.

PMID: 39922978 PMC: 11807095. DOI: 10.1038/s42003-025-07557-3.


Structural analysis of human ADAR2-RNA complexes by X-ray crystallography.

Campbell K, Cheng J, Mendoza H, Karki A, Beal P, Fisher A Methods Enzymol. 2025; 710:19-53.

PMID: 39870445 PMC: 11881785. DOI: 10.1016/bs.mie.2024.11.023.


References
1.
Maas S, Kawahara Y, Tamburro K, Nishikura K . A-to-I RNA editing and human disease. RNA Biol. 2006; 3(1):1-9. PMC: 2947206. DOI: 10.4161/rna.3.1.2495. View

2.
Nishikura K . Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 2010; 79:321-49. PMC: 2953425. DOI: 10.1146/annurev-biochem-060208-105251. View

3.
Lau A, Scharer O, Samson L, Verdine G, Ellenberger T . Crystal structure of a human alkylbase-DNA repair enzyme complexed to DNA: mechanisms for nucleotide flipping and base excision. Cell. 1998; 95(2):249-58. DOI: 10.1016/s0092-8674(00)81755-9. View

4.
Mannion N, Greenwood S, Young R, Cox S, Brindle J, Read D . The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep. 2014; 9(4):1482-94. PMC: 4542304. DOI: 10.1016/j.celrep.2014.10.041. View

5.
Eggington J, Greene T, Bass B . Predicting sites of ADAR editing in double-stranded RNA. Nat Commun. 2011; 2:319. PMC: 3113232. DOI: 10.1038/ncomms1324. View